The effectiveness of adalimumab maintenance treatment for Crohn's disease and related prognostic factors: a Japanese single-center study

被引：0
|
作者：
Tanaka, H. [1 ]
Miyakawa, M. [1 ]
Nasuno, M. [1 ]
Motoya, S. [1 ]
Imamura, A. [1 ]
机构：
[1] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60444-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P323
引用
收藏
页码：S199 / S200
页数：3
相关论文
共 50 条
  • [1] The effectiveness of adalimumab maintenance treatment for crohn's disease and related prognostic factors: a japanese single-center study
    Tanaka, Hiroki
    Miyakawa, Maki
    Sakemi, Ryosuke
    Nasuno, Masanao
    Motoya, Satoshi
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 134 - 134
  • [2] Long-term outcomes and related prognostic factors of adalimumab maintenance treatment for patients with Crohn's disease: A Japanese single-center cohort study
    Tanaka, Hiroki
    Sugiyama, Kohei
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 466 - 466
  • [3] Long-term Outcomes and Related Prognostic Factors of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease: A Single-center Cohort Study
    Tanaka, Hiroki
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S317 - S317
  • [4] Long-term outcome and related prognostic factors of infliximab maintenance treatment for Japanese patients with Crohn's disease: A Japanese single-center study
    Miyakawa, Maki
    Tanaka, Hiroki
    Sugiyama, Kohei
    Nasuno, Masanao
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 110 - 110
  • [5] Long-term Operation Rates and Related Prognostic Factors in Patients with Crohn's Disease Treated by Infliximab: A Japanese Single-center Cohort Study
    Nasuno, Masanao
    Miyakawa, Maki
    Tanaka, Hiroki
    Motoya, Satoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S300 - S300
  • [6] Long-term outcome of infliximab maintenance treatment for patients with Crohn's disease: A Japanese single-center cohort study
    Nasuno, Masanao
    Tanaka, Hiroki
    Sugiyama, Kohei
    Miyakawa, Maki
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 466 - 466
  • [7] Postoperative adalimumab maintenance therapy for Japanese patients with Crohn’s disease: a single-center, single-arm phase II trial (CCOG-1107 study)
    Takahiro Asada
    Goro Nakayama
    Chie Tanaka
    Daisuke Kobayashi
    Kazuhiro Ezaka
    Norifumi Hattori
    Mitsuro Kanda
    Suguru Yamada
    Masahiko Koike
    Yasuhiro Kodera
    Surgery Today, 2018, 48 : 609 - 617
  • [8] Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study)
    Asada, Takahiro
    Nakayama, Goro
    Tanaka, Chie
    Kobayashi, Daisuke
    Ezaka, Kazuhiro
    Hattori, Norifumi
    Kanda, Mitsuro
    Yamada, Suguru
    Koike, Masahiko
    Kodera, Yasuhiro
    SURGERY TODAY, 2018, 48 (06) : 609 - 617
  • [9] Mid- to Long-Term Outcomes of Adalimumab Maintenance Treatment for Japanese Patients with Crohn's Disease and Associated Prognostic Factors
    Tanaka, Hiroki
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S28 - S29
  • [10] Dose escalation of adalimumab and related prognostic factors in patients with Crohn's disease treated with adalimumab maintenance therapy: A single-centre, five-year cohort study
    Nasuno, M.
    Tanaka, H.
    Sugiyama, K.
    Miyakawa, M.
    Motoya, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S314 - S314
12345